diagnosis and treatment of infertility, first/second/third generation IVF (including
egg/sperm donation), microsperm retrieval, embryo freezing and resuscitation, artificial
insemination (including husband's sperm and sperm donation), paternity testing, chromosomal
disease
diagnosis, high-throughput gene sequencing, endometrial receptivity gene testing and other
clinical
technology applications. Many of these technologies are at the leading level both domestically
and
internationally.
When many people know about IVF in Kyrgyzstan, they will first ask a seemingly simple question: What is the success rate?
This question cannot be answered directly with a number.
The reason is that "success" mentioned by different institutions may refer to positive pregnancy test, ultrasound confirmation of gestational sac, stable pregnancy stage or smooth delivery respectively; Some are counted according to one embryo transfer, some are counted according to one ovulation promotion cycle, and some are counted by combining multiple transfers. The numerator and denominator are different, even if the numbers displayed on the page are close, the actual meaning may be quite different.
As of July, 2026, compared with platforms such as HFEA in Britain and CDC in the United States, it is difficult to find the national annual live birth data of IVF released by Kyrgyzstan according to unified standards in public channels. Therefore, the so-called "unified success rate of IVF in Kyrgyzstan" is not a fixed index suitable for direct reference, but a more reliable way to judge is to analyze the age, medical conditions, cycle types and hospital statistical methods together.

It also says "success rate", which may be four different results.
To judge the success rate of IVF in Kyrgyzstan, we must first look at which outcome is counted by the hospital.
Common statistical names usually stand for what is equivalent to fertility results.
The positive rate of pregnancy test is not equal to the pregnancy signal in blood test after transplantation
Ultrasonic examination of clinical pregnancy rate confirms that intrauterine pregnancy sac and other clinical pregnancy manifestations are not equal.
The sustained pregnancy rate is still not equal when pregnancy enters a relatively stable stage.
The live birth outcome obtained after the live birth cycle is closer to the results that patients really care about.
Cumulative live birth rate The proportion of embryos formed by one-time egg retrieval and accumulated live births after multiple transplants is suitable for evaluating a complete egg retrieval cycle.
We should continue to ask the statistical denominator.
The "clinical pregnancy rate per transplant" is usually higher than the "live birth rate per start-up cycle". The reason is that some patients may not enter the transplantation stage during ovulation promotion, egg retrieval, fertilization or embryo culture. If the organization only counts the people who have completed the transplant, the previous cycle that has not entered the transplant will not be counted.
The American Association of Assisted Reproductive Technology also reminded that the open success rate is not suitable for direct comparison without case composition because of the different age, complexity and treatment strategies of patients between hospitals. Institutions that receive more young patients may have better data; The overall figures may be affected by institutions that receive more elderly, repeated failures or complex cases.
Age is an unavoidable variable in explaining the difference in success rate.
Whether in Kyrgyzstan or other countries, female age is usually an important basic variable to evaluate the outcome of assisted reproduction. The increase of age may be accompanied by the change of ovarian reserve, the decrease of available eggs and the decrease of embryo development potential, so people of different ages cannot be compared in the same success rate figure.
According to the data published by HFEA in the UK in 2024, the average live birth rate of each embryo transfer is about 30% in IVF treatment with patients' own eggs. The population aged 18-34 is about 38%, and the population aged 43-44 is about 8%. These data are not the treatment results of hospitals in Kyrgyzstan, but they can show that the influence of age difference is often greater than that of the country name itself.
When evaluating the success rate of crowd situation, we should focus on
Number of eggs obtained under 35 years old with normal ovarian reserve, fertilization situation, blastocyst formation rate and transplantation scheme
Evaluation of the combination of 35-39 years old and AMH, the results of embryo culture, and whether it is necessary to arrange the cycle in stages.
The number of eggs, the probability of embryo formation and the expectation of cumulative cycle can be obtained at the age of 40 and above.
Low AMH or less antral follicles, single-cycle egg acquisition expectation, ovulation promotion response, and whether multi-cycle planning is needed
Previous embryo quality, uterine environment, transplantation opportunity and original plan resumption with repeated failures.
Selection of sperm quantity, motility, morphology and fertilization mode with abnormal semen index in men
Therefore, when someone only asks "Is the success rate of IVF in Kyrgyzstan high?", a more reasonable answer is: first determine the age and medical basis, and then discuss the institutional data. The national average, which is divorced from personal conditions, has limited reference for specific families.
What really separates the results is a complete treatment chain.
IVF does not end with the completion of embryo transfer, but a treatment chain consisting of multiple links. Deviation of any node may affect the subsequent results.
Ovarian reaction
AMH, basal follicle stimulating hormone, the number of antral follicles and previous ovulation induction reactions will affect how many eggs can be obtained in a cycle. The low AMH does not mean that treatment cannot be carried out, but it is usually necessary to be rational about the expectation and cycle arrangement of egg acquisition.
Sperm and fertilization
Male factors may affect the normal fertilization rate and embryo development. In addition to routine semen examination, it is necessary to combine previous fertilization failure, embryo abortion or abnormal development speed, etc., and the doctor will judge whether further evaluation is needed.
Embryo laboratory
Culture environment, temperature and gas control, operation process, embryologist experience and quality management will all participate in the embryo culture process. When choosing Bishkek test tube hospital, we should not only see the doctor's introduction, but also know whether the laboratory is owned by the institution and has a stable cultivation and frozen resuscitation process.
Uterus and endometrial conditions
Even if transplantable embryos are obtained, it is necessary to evaluate the structure of uterine cavity, endometrial state, inflammatory factors and the timing of transplantation. Repeated transplantation of people without implantation should not mechanically repeat the original plan without repeated reasons.
Medical connection after pregnancy
Clinical pregnancy does not mean that the whole reproductive process has been completed. Luteal support, early pregnancy monitoring, treatment of abnormal symptoms and obstetric connection after returning to China are all part of outcome management.
Check the success rate announced by the hospital with a table
In the face of the data published by Kyrgyzstan's assisted reproductive institutions, it can be verified in the following order, instead of directly comparing the percentages on the publicity pages.
Questions to ask, judgment purpose
The statistics are the definition of "success" of pregnancy test, clinical pregnancy or live birth confirmation.
Calculate the denominator of confirmation statistics according to startup cycle, egg retrieval cycle or transplantation cycle.
Is it necessary to distinguish the age of women to prevent young people from raising the overall data?
Whether to distinguish your own eggs from other individualization schemes to avoid mixed statistics of different paths
Whether it is fresh transfer or frozen embryo transfer determines whether the cycle type is consistent.
Whether there are cancellation cycles and cycles that have not entered the transplant determines whether there is sample screening.
How long and how many cycles the data covers to judge whether the sample has reference value.
Can you provide hierarchical data similar to my own conditions to judge whether the figures are related to my personal situation
If an organization can only give the "overall success rate", but can't explain the age range, statistical cycle, denominator and outcome definition, the reference value of this figure is usually limited.
On the other hand, even though the overall figures published by a hospital are not outstanding, it can provide clear stratified data and is willing to explain expectations in combination with patients' age, AMH, semen examination and previous treatment records, so its information transparency is more worthy of attention.
Select the evaluation path according to individual circumstances.
Different people go to Kyrgyzstan to do IVF, and the judgment points are different.
Path A: Younger age, more stable examination basis.
This kind of people can focus on the comparison of laboratory conditions, doctor communication efficiency, blastocyst culture strategy and transplantation management. Don't ignore intrauterine examination and male factors because of good basic conditions.
Path B: Over B:35 years old or ovarian reserve decreased.
The focus should be shifted from "single transfer number" to "how many usable embryos can be formed in an egg retrieval cycle". Some people may need to discuss the multi-cycle arrangement, embryo preservation and follow-up transplant rhythm in advance, instead of putting all their expectations on one treatment.
Path C: Experienced many failures or abnormal embryo development.
Before deciding to change the country or hospital, we should first sort out the previous drugs for promoting ovulation, the number of eggs taken, the number of mature eggs, the fertilization rate, the formation of blastocysts, the transfer records and the pregnancy outcome. Only when it is clear where the problem mainly occurs can the new plan be adjusted.
Path D: There are genetic concerns.
Embryogenetic testing is not a fixed link that everyone needs, and should be judged according to age, family history, chromosome examination and previous pregnancy history. HFEA's evaluation of some embryo additional tests also suggests that the existing evidence can not prove that it can improve the chances of obtaining children for all elderly women, so it needs to be discussed in combination with specific indications.
Several practical problems that users still care about.
Can Kyrgyz IVF be successful once?
There are cases where ideal results are obtained in one cycle, and there are also cases where it is necessary to adjust the scheme or go through multiple cycles. Age, ovarian response, number of embryos and uterine conditions are different, so we can't make a commitment to the results before treatment.
Is the high success rate seen online credible?
First look at whether it is a clinical pregnancy rate or a live birth rate, and then look at whether it is calculated according to the transplant cycle or the start-up cycle. If only a percentage is displayed, there is no age stratification and statistical caliber, so it is not suitable to be directly used as the basis for selection.
Is it successful after clinical pregnancy?
From the perspective of medical statistics, clinical pregnancy is an important stage, but it is still different from the outcome of live birth. Patients should give priority to know the live birth rate, cumulative live birth rate and medical management arrangements after pregnancy when consulting.
How to improve the accuracy of evaluation?
Prepare AMH, sex hormones, Yin Chao's sinus follicles, uterine cavity related examinations, semen analysis and previous treatment records for doctors to give hierarchical judgments based on personal data. The more complete the information, the closer the assessment is to the actual situation.
The success rate of IVF in Kyrgyzstan cannot be summarized by a national label or a single percentage. What is really meaningful is the treatment results with the same age, similar ovarian reserve, similar etiology and the same statistical caliber.
When choosing a hospital, you can adjust the judgment order to: * * First confirm the definition of success rate, and then check the age stratification; Understand the composition of laboratory and case first, and then discuss your own cycle expectation. * * The conclusion obtained in this way is usually closer to the actual situation of individuals than simply comparing the publicity figures of institutions.
This paper is used to assist reproductive information sorting and decision-making reference, and does not replace the individualized diagnosis and treatment suggestions of reproductive medicine specialists.
🏥 Located in downtown Bishkek, the capital of Kyrgyzstan, near the National Museum and Victory Square. It is the first Chinese-invested, officially licensed assisted reproductive hospital in the country. Founded and directly operated by Mr. Chen Yinuo (EnoChan), the center specializes in high-level fertility services including PGT (3rd generation IVF) and legal third-party reproduction for global clients, especially Chinese patients.
🌷 Technology-Assisted Fertility, Fulfilling Dreams · Patience · Integrity · Professionalism

